Jamie Daw
Jamie Daw
Columbia University Mailman School of Public Health
Verified email at columbia.edu - Homepage
Title
Cited by
Cited by
Year
Prescription drug use during pregnancy in developed countries: a systematic review
JR Daw, GE Hanley, DL Greyson, SG Morgan
Pharmacoepidemiology and drug safety 20 (9), 895-902, 2011
2422011
Stitching the gaps in the Canadian public drug coverage patchwork? A review of provincial pharmacare policy changes from 2000 to 2010
JR Daw, SG Morgan
Health Policy 104 (1), 19-26, 2012
1202012
Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001–2006)
JR Daw, B Mintzes, MR Law, GE Hanley, SG Morgan
Clinical therapeutics 34 (1), 239-249. e2, 2012
1132012
Estimated cost of universal public coverage of prescription drugs in Canada
SG Morgan, M Law, JR Daw, L Abraham, D Martin
CMAJ 187 (7), 491-497, 2015
1022015
Matching and regression to the mean in difference‐in‐differences analysis
JR Daw, LA Hatfield
Health services research 53 (6), 4138-4156, 2018
922018
Women in the United States experience high rates of coverage ‘churn’in months before and after childbirth
JR Daw, LA Hatfield, K Swartz, BD Sommers
Health Affairs 36 (4), 598-606, 2017
802017
Rethinking Pharmacare in Canada
SG Morgan, JR Daw, MR Law
CD Howe Institute, 2013
512013
The future of drug coverage in Canada
SG Morgan, D Martin, MA Gagnon, B Mintzes, JR Daw, J Lexchin
482015
Association of the Affordable Care Act dependent coverage provision with prenatal care use and birth outcomes
JR Daw, BD Sommers
Jama 319 (6), 579-587, 2018
392018
Growth in private payments for health care by Canadian households
MR Law, JR Daw, L Cheng, SG Morgan
Health Policy 110 (2-3), 141-146, 2013
382013
International best practices for negotiating ‘reimbursement contracts’ with price rebates from pharmaceutical companies
S Morgan, J Daw, P Thomson
Health Affairs 32 (4), 771-777, 2013
362013
Here today, gone tomorrow: the issue attention cycle and national print media coverage of prescription drug financing in Canada
JR Daw, SG Morgan, PA Thomson, MR Law
Health policy 110 (1), 67-75, 2013
342013
Canadian pharmacare: looking back, looking forward
SG Morgan, JR Daw
Healthcare Policy 8 (1), 14, 2012
322012
The Affordable Care Act and access to care for reproductive-aged and pregnant women in the United States, 2010–2016
JR Daw, BD Sommers
American journal of public health 109 (4), 565-571, 2019
262019
Racial and ethnic disparities in the use of antipsychotic medication: a systematic review and meta-analysis
JH Puyat, JR Daw, CM Cunningham, MR Law, ST Wong, DL Greyson, ...
Social psychiatry and psychiatric epidemiology 48 (12), 1861-1872, 2013
252013
Preconception coverage before and after the Affordable Care Act Medicaid expansions
MA Clapp, KE James, AJ Kaimal, JR Daw
Obstetrics & Gynecology 132 (6), 1394-1400, 2018
212018
Seeking safe stool: Canada needs a universal donor model
C Edelstein, JR Daw, Z Kassam
Cmaj 188 (17-18), E431-E432, 2016
202016
Use of product listing agreements by Canadian provincial drug benefit plans
SG Morgan, MK Friesen, PA Thomson, JR Daw
Healthcare Policy 8 (4), 45, 2013
202013
Canadian policy makers’ views on pharmaceutical reimbursement contracts involving confidential discounts from drug manufacturers
SG Morgan, PA Thomson, JR Daw, MK Friesen
Health Policy 112 (3), 248-254, 2013
192013
Matching in difference‐in‐differences: between a rock and a hard place
JR Daw, LA Hatfield
Health services research 53 (6), 4111, 2018
172018
The system can't perform the operation now. Try again later.
Articles 1–20